Curemark, LLC is a biopharmaceutical company focused on developing precision medicine therapies for neurodevelopmental disorders, including autism spectrum disorder. Their proprietary diagnostic and therapeutic technologies aim to address underlying metabolic dysfunctions to improve patient outcomes.